Publications

Results 745 to 756 of 3892

22 September 2020

Representation of adverse childhood experiences is associated with lower public stigma towards people who use drugs: an exploratory experimental study

Sumnall et al.'s research suggests insights into the life histories of people who experience challenges related to their drug use can elicit less stigmatising responses.

22 September 2020

Rights in a pandemic – Lockdowns, rights and lessons from HIV in the early response to COVID-19

UNAIDS offers a pandemic response guide focusing on justice, access to services and participation, while highlighting the impacts public health measures have on the most vulnerable.

11 September 2020

Global Drug Survey COVID-19 special edition: Key findings report

This GDS edition focused on the impact of the pandemic on people's use of drugs, mental health and relationships.

11 September 2020

Estratégia regional para o VIH, tuberculose, hepatite B & C e saúde reprodutiva e sexual e direitos entre as populações-chave na CEDEAO

A CEDEAO reconhece a importância de garantir o acesso aos serviços de redução de danos, removendo as barreiras socio-estruturais, incluindo através da descriminalização.

11 September 2020

ECOWAS regional strategy for HIV, tuberculosis, hepatitis B & C and sexual and reproductive health and rights among key populations

ECOWAS acknowledges the importance of ensuring access to harm reduction services by removing socio-structural barriers, including through decriminalisation.

11 September 2020

“Coming out”: Stigma, reflexivity and the drug researcher’s drug use

Ross et al. discuss dynamics of risk and privilege concerning the lived/living experiences of drug researchers who use drugs.

10 September 2020

‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work

A.Greer et. all highlight peer workers are particularly vulnerable to precarious working conditions, entrenching inequities and imperilling the harm reduction response.

10 September 2020

Recreational cannabis regulation and harm reduction - BERL reports to the New Zealand Ministry of Justice

BERL costs the potential impact of a legal cannabis market in New Zealand / Aotearoa.

9 September 2020

Principles for the responsible legal regulation of cannabis

IDPC presents twenty principles to guide the responsible legal regulation of cannabis markets.

7 September 2020

Understanding the sexual health and blood borne virus risk behaviours of defined 'at risk' groups to inform a service training programme

The Scottish Drugs Forum inventories the needs of three specific communities of people who use drugs to facilitate training and service development.

7 September 2020

Overdose education and naloxone distribution within syringe service programs — United States, 2019

Barrot et al. report increased provision of opioid overdose education and naloxone distribution in needle and syringe programmes in the US, but coverage remains unequal.

7 September 2020

Drug policies and development - Conflict and coexistence

The publication addresses the drugs and development nexus from a range of critical viewpoints, highlighting gaps and contradictions, and exploring opportunities for enhanced linkages between drug policy and development programming.